Search research articles
Contact Us
Filters
Showing results (101-110 of 112) with videos related to
Page
of 12
Sort By:
Lancet (London, England)
|
April 29, 2008
Treatment and outcomes of acute coronary syndromes in India (CREATE): a prospective analysis of registry data
Denis Xavier, Prem Pais, P J Devereaux, et al.
Plos Neglected Tropical Diseases
|
September 27, 2013
Atypical human infections by animal trypanosomes
Philippe Truc, Philippe Büscher, Gérard Cuny, et al.
European Journal of Medicinal Chemistry
|
February 22, 2017
Discovery and characterization of novel CYP1B1 inhibitors based on heterocyclic chalcones: Overcoming cisplatin resistance in CYP1B1-overexpressing lines
Neill J Horley, Kenneth J M Beresford, Tarun Chawla, et al.
Blood Cancer Journal
|
November 11, 2024
Impact of lenalidomide-bortezomib-dexamethasone induction on patients with newly diagnosed multiple myeloma and renal impairment: Results from the Connect® MM Registry
Sikander Ailawadhi, Hans C Lee, James Omel, et al.
Blood Cancer Journal
|
July 24, 2021
Treatment patterns and outcomes in elderly patients with newly diagnosed multiple myeloma: results from the Connect<sup>®</sup> MM Registry
Hans C Lee, Sikander Ailawadhi, Cristina J Gasparetto, et al.
Practical Radiation Oncology
|
November 20, 2023
Real-World Utilization of Radiation Therapy in Multiple Myeloma: An Analysis of the Connect MM Registry
Leslie Ballas, Sikander Ailawadhi, Mohit Narang, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
November 27, 2024
Characteristics and Treatment Patterns of Long-surviving Patients With Multiple Myeloma: Over 13 Years of Follow-up in the Connect<sup>Ⓡ</sup> MM Registry
Howard R Terebelo, James Omel, Lynne I Wagner, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
December 25, 2022
Treatment Patterns, Survival, Quality of Life, and Healthcare Resource Use Among Patients With Triple-Class Refractory Multiple Myeloma in US Clinical Practice: Findings From the Connect MM Disease Registry
Hans C Lee, Karthik Ramasamy, Katja Weisel, et al.
Organic & Biomolecular Chemistry
|
April 22, 2015
Colchicine derivatives with potent anticancer activity and reduced P-glycoprotein induction liability
Baljinder Singh, Ashok Kumar, Prashant Joshi, et al.
The Journal of Antimicrobial Chemotherapy
|
December 17, 2019
In vitro activity of a novel antibacterial agent, levonadifloxacin, against clinical isolates collected in a prospective, multicentre surveillance study in India during 2016-18
Boppe Appalaraju, Sujata Baveja, Shrikala Baliga, et al.
Page
of 12
Search research articles
Search
Showing results (101-110 of 112) with videos related to
Sort By:
Page
of 12
Lancet (London, England)
|
April 29, 2008
Treatment and outcomes of acute coronary syndromes in India (CREATE): a prospective analysis of registry data
Denis Xavier, Prem Pais, P J Devereaux, et al.
Plos Neglected Tropical Diseases
|
September 27, 2013
Atypical human infections by animal trypanosomes
Philippe Truc, Philippe Büscher, Gérard Cuny, et al.
European Journal of Medicinal Chemistry
|
February 22, 2017
Discovery and characterization of novel CYP1B1 inhibitors based on heterocyclic chalcones: Overcoming cisplatin resistance in CYP1B1-overexpressing lines
Neill J Horley, Kenneth J M Beresford, Tarun Chawla, et al.
Blood Cancer Journal
|
November 11, 2024
Impact of lenalidomide-bortezomib-dexamethasone induction on patients with newly diagnosed multiple myeloma and renal impairment: Results from the Connect® MM Registry
Sikander Ailawadhi, Hans C Lee, James Omel, et al.
Blood Cancer Journal
|
July 24, 2021
Treatment patterns and outcomes in elderly patients with newly diagnosed multiple myeloma: results from the Connect<sup>®</sup> MM Registry
Hans C Lee, Sikander Ailawadhi, Cristina J Gasparetto, et al.
Practical Radiation Oncology
|
November 20, 2023
Real-World Utilization of Radiation Therapy in Multiple Myeloma: An Analysis of the Connect MM Registry
Leslie Ballas, Sikander Ailawadhi, Mohit Narang, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
November 27, 2024
Characteristics and Treatment Patterns of Long-surviving Patients With Multiple Myeloma: Over 13 Years of Follow-up in the Connect<sup>Ⓡ</sup> MM Registry
Howard R Terebelo, James Omel, Lynne I Wagner, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
December 25, 2022
Treatment Patterns, Survival, Quality of Life, and Healthcare Resource Use Among Patients With Triple-Class Refractory Multiple Myeloma in US Clinical Practice: Findings From the Connect MM Disease Registry
Hans C Lee, Karthik Ramasamy, Katja Weisel, et al.
Organic & Biomolecular Chemistry
|
April 22, 2015
Colchicine derivatives with potent anticancer activity and reduced P-glycoprotein induction liability
Baljinder Singh, Ashok Kumar, Prashant Joshi, et al.
The Journal of Antimicrobial Chemotherapy
|
December 17, 2019
In vitro activity of a novel antibacterial agent, levonadifloxacin, against clinical isolates collected in a prospective, multicentre surveillance study in India during 2016-18
Boppe Appalaraju, Sujata Baveja, Shrikala Baliga, et al.
Page
of 12